OCVIMOY
Live / Allowed — Second extension granted (statement of use) (as of 07 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Oct 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98783752
- Mark type
- Word mark
- Filed
- 03 Oct 2024
- Published for opposition
- 13 May 2025
- Attorney of record
- Keith Barritt
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye disease
Owner
- Alkeus Pharmaceuticals, Inc., Cambridge, MA, US
- Alkeus Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 07 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2026 — SOU EXTENSION 2 GRANTED
- 06 May 2026 — SOU EXTENSION 2 FILED
- 06 May 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — SOU EXTENSION 1 GRANTED
- 23 Dec 2025 — SOU EXTENSION 1 FILED
- 23 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 May 2025 — PUBLISHED FOR OPPOSITION
- 07 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Apr 2025 — ASSIGNED TO EXAMINER
- 07 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED